The fertility supplements market size is set to grow by $819.22M between 2021 and 2026 and register a CAGR of 7.53%, according to Technavio's report.
The fertility supplements market growth in the women segment will be significant during the forecast period. Infertility is a worldwide health issue that affects 20%-30% of women of reproductive age. According to a datasheet released by the Population Reference Bureau (PRB), in August 2021, the fertility rate for women of all ages in high- and low-income countries has been declining since 1950. PCOS, endometriosis, premature ovarian failure, and pelvic inflammatory disease are just a few of the systemic and gynecological disorders that can impair the female reproductive system and lead to infertility. Such factors will contribute to segment growth in the forecast years.
North America will account for 36% of the market growth during the forecast period. The US is the leading market for fertility supplements in North America. The market growth in this region will be faster than that of South America and MEA. Rising infertility rates and rising public awareness of overall health will propel the growth of the North American fertility supplement market during the forecast period.